Freedom Pack
₹0 for Equity Delivery
₹20/ orderfor Intraday and F&O Trades
18% per annumMTF
Professional Pack
₹10/ orderfor Intraday and F&O Trades
12.5% per annumMTF
Bajaj Privilege Pack
₹5/ orderfor Intraday and F&O Trades
One of the Lowest MTF Interest Rates
PharmEasy, a pharmacy startup run by API Holdings, is all set to make a public debut for its Initial Public Offering (IPO) to raise Rs. 6,250 Crores through the fresh issue. A Draft Red Herring Prospectus (DRHP) was filed by the company on November 10. The company is currently in discussions with bankers and may consider a private placement amounting to Rs. 1,250 crores. However, the implementation of private placement could narrow down the fresh issue.
Here is the break-up for the share allotment.
PharmEasy offers a dedicated healthcare platform offering a wide range of services, including diagnostic tests, online medicines and doctor consultations. Dharmil Sheth and Dr Dhaval Shah founded the company in 2015. The company acquired Medlife, Aknamed and Thyrocare earlier this year. Medlife is a publicly listed diagnostic chain, while Thyrocare and Aknamed are cloud-based hospital supply chain management startups.
The objectives for PharmEasy IPO are stated below:
Here are a few driving factors for you to invest in PharmEasy shares.
You can apply for PharmEasy IPO by placing bids from your Demat account. Alternatively, the UPI-based approach can also help you apply for the offering through the following steps.
Open Demat & Trading Account
PharmEasy is floating an IPO to raise Rs. 6,250 crores to manage existing debts and aid different corporate purposes.
The details are currently unavailable. However, PharmEasy unlisted share price is Rs. 115/share.
PharmEasy witnessed a growth of 220% in FY 2021. The company generated a revenue of Rs. 2,360 crores compared to Rs. 737.4 crores in 2020.
PharmEasy runs a healthcare e-commerce app offering an extensive range of facilities such as various diagnostic tests services, home delivery of consumer health products, teleconsultation services, OTC pharmaceuticals and much more.
Yes. PharmEasy is a startup company that offers a dedicated healthcare platform offering a wide range of services, including diagnostic tests, online medicines and doctor consultations.
Get account within 15 minutes, 100% digital process!